But the medication itself, as long as its in the pen, its not going to cause a problem
R.B wrote main manuscript text, and created Table 3
Summary Although GLP-1R agonists were originally developed for glycemic control in DM, their mechanistic versatility has enabled broader application across a spectrum of cardiovascular, cerebrovascular and metabolic disorders
How does the evolution of obesity pharmacotherapy, from early appetite-suppressant drugs to modern GLP-1 receptor agonists, reflect advancements in our understanding of metabolic processes and patient safety concerns
Lovelle emphasizes that lifestyle interventions are critical to long-term success
Additionally, 95 % CI were calculated for calories, macronutrients, and fiber intake reported for breakfast, lunch, dinner, and snacks